Britain’s music industry, the EU, the UK – and an early entry for Frost’s inbox

2 Mar

Some post-Brexit barriers to business between the UK and the EU are a consequence of both parties failing to clinch an agreement that one or the other or both already have with third parties – in which the loser is the industry concerned, on both sides of the channel.

Others are a product of our own bureaucracy: of government being ponderous when it might be nimble in offering advice and support.

And others still are simply a product of Brexit as we agreed it, which brings with it friction in trade with the EU, which in turn can be minimised but not eliminated.

The continuing row over the access of British musicians to the EU and EU musicians to Britain offers examples of all three.

In the first category, we have visas.  Some EU states will allow our musicians to visit without a visa for up to 90 days and other won’t.  That isn’t a problem for other third party states, such as St Lucia, Tonga or those which make up the United Arab Emirates, because they have a bileteral deal with the EU that waives the requirement.

In the second, there is VAT. UK exporters of physically recorded music and merchandise must go from paying no VAT to negotiating 27 different EU VAT systems to dealing with a single EU VAT system during this current year.  This is a classic instance of the businesses concerned needing more advice from the government as it seeks to navigate two systems within twelve months.

Finally, there will be more bureaucracy, admin and paperwork – even if the UK and the EU can sort that visa issue, and others that could reasonably be settled (such as carnets, for which there may already be an exemption for portable musical instruments taken into the EU for professional purposes).

That last category is integral to leaving the Single Market and Customs Union – which is outweighed, to some Brexiteers, by the regaining of national independence and, to others, by the gains that come from being outside the EU system and willing to act on it.  Our vaccine success alone could be worth “more than the most pessimistic assumptions about the economic damage of Brexit,” according to Jethro Elsden of the Centre for Policy Studies.

(Northern Ireland, of course, remains in the Single Market for goods and, in key respects, in the Customs Union too for practical purposes.)

Why the difficulty over negotiating a deal on visa waivers or work permits?  Because musicians are caught up in a wider issue of which their story is part: freedom of movement.

To cut a long story short, the EU made a public offer on the issue, which had wider implications for free movement, and the UK made a private one, that did not.

The former would have applied not only to musicians but to other workers and travellers, as Free Movement confirms.  But, for many people who backed Brexit, ending it was integral to the exercise.

Our proprietor’s EU referendum day poll of over 12,000 people found that a third of those who voted Leave said the main reason was that leaving “offered the best chance for the UK to regain control over immigration and its own borders.”

Meanwhile, Oliver Dowden says that “the reason why we rejected the offer from the European Union was that it wasn’t binding, it didn’t cover touring, it didn’t cover technical support staff, and crucially, it didn’t cover work permits.”

This continuing impasse is an early bidder for entry near the top of David Frost’s inbox as he begins only his second day as a member of the Cabinet – though if the free movement obstacle remains immovable, there will be little he can wring out of the EU.

However, Frost knows the ropes, having led the negotiation on the trade deal himself, and is so is well-placed to knock on the doors of individual member states, into whose hands most of these matters fall in the absence of an EU-wide agreement.

UK Music argues that “fishing is of course an important British industry, contributing £446 million to the UK economy in 2019 and employing 12,000 fishers”.

“But it pales in comparison with the UK music industry, which in the same year contributed £5.8 billion to the economy and supported 200,000 jobs.”

It is strange to think that there is more money in Peter Grimes, figuratively speaking, than there is in real fishing – even if because there is less than there might be because of the dispute.

There will be a £23 million fund for fisheries, and Music UK proposes, by way of parallel, a music exports office to help the sector cope with the increased bureaucracy.

Perhaps Rishi Sunak will make an offer tomorrow – after all, today’s papers are full of pre-briefing, as is way with modern Budgets, of £400 million more for theatres, museums, galleries and live music venues.

Macron and others played politics with AstraZeneca. The consequences for many EU citizens are fatal.

24 Feb

In January this year, many will remember Emmanuel Macron telling reporters, in no uncertain terms, what he thought about the vaccine developed by AstraZeneca and Oxford University.

Today we think that it is quasi-ineffective for people over 65”, he said, hours before the European Medicines Agency recommended it for adults of all ages. “[T]he early results we have are not encouraging for 60 to 65-year-old people concerning AstraZeneca”, the French president warned, as well as criticising Britain’s strategy of delaying the second dose of the vaccine to get the first one out quickly – in another act of incredible diplomacy.

Days earlier a German newspaper incorrectly claimed the AstraZeneca jab is only eight per cent effective in the over-65s. While the figure was quickly dismissed, several countries haven’t exactly inspired confidence in AstraZeneca’s efficacy. Germany advised that it should not be given to people aged 65 or above, citing “insufficient data”, and France, Switzerland, Denmark, Sweden and Norway have also recommended it only for younger people.

Ursula von der Leyen, the European Commission Chief, even went so far as to accuse the UK of compromising on “safety and efficacy” safeguards in delivering its vaccines. And Clément Beaune, France’s Europe Minister, warned “the British are in an extremely difficult health situation. They are taking many risks in this vaccination campaign.” You don’t have to be a Brexiteer to get the idea: British vaccines = bad. Even John Bell, a medical professor at Oxford University, accused Macron trying to reduce demand for vaccines to cover up the EU’s huge issues with procurement, culminating in its dangerous attempt to control vaccine exports across the Irish border.

So one wonders what the mood is in Brussels now that research has revealed just what a success the much-attacked AstraZeneca vaccine has been. A study in Scotland, where 1.14 million people were vaccinated between December 8 and February 15, showed that both the AstraZeneca and Pfizer vaccines led to a “very substantial” drop in serious illness across all adult age groups.

Critically, researchers found that by the fourth week after receiving an initial dose of each vaccine, the risk of hospitalisation from Covid-19 reduced by up to 85 per cent (Pfizer) and 94 per cent (AstraZeneca), in a result that will please people who’ve had it – but raise serious questions about the language and policies of EU leaders.

Their actions have fuelled vaccine hesitancy. In Germany, for instance, people have failed to turn up to appointments for the AstraZeneca vaccine. As of Friday, only 150,000 out of 1.5 million doses of the vaccine had been used – leaving the country with less than six per cent of its population immunised (compared to 26 per cent for Britain).

There are also reports of hospital workers in France and Belgium demanding that they be given the Pfizer jab instead of AstraZeneca (one nurse in a Flemish hospital even told a publication she would go on strike if offered the latter). Politicians have failed to convey the bigger picture; that everyone is lucky to be offered one vaccine with high efficacy rates (50 per cent protection would have been a good outcome), let alone that several have been developed.

As Ryan Bourne and Jethro Elsden have already written for ConservativeHome, the EU’s difficulties in procuring vaccines is dangerous enough in itself – Bourne estimates the UK has saved around nine thousand lives by choosing its own vaccination programme, and Elsden says the country has gained approximately £100 billion from doing this.

The fact that some EU leaders have added to this chaos by planting doubts about AstraZeneca’s vaccine makes the situation even more alarming. The vulnerable are less protected, and – on a global scale – if we do not get transmission of the virus down, it can mutate and mean that the current vaccines do not work.

Some leaders realise the seriousness of the problem. Michael Müller, the mayor of Berlin, has warned that people could be sent to the back of the queue for vaccines if they refuse an AstraZeneca job. “I won’t allow tens of thousands of doses to lie around on our shelves while millions of people across the country are waiting to be immunised”, were his words, and Angela Merkel’s spokesman has pleaded with Germans to take the “safe and highly effective” jab.

It’s a start, but terrible that so much damage has already been done. Some might remember that in November 2020, MPs here debated whether social media companies should be doing more to remove anti-vaccine disinformation. Never could they have imagined it would be Macron spreading some of the most troublesome ideas.